ASR Vermogensbeheer’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,174
Closed -$876K 528
2026
Q1
$876K Buy
4,174
+77
+2% +$19.4K 0.01% 441
2025
Q4
$1.16M Sell
4,097
-38
-0.9% -$11.9K 0.01% 419
2025
Q3
$1.28M Sell
4,135
-23
-0.6% -$7.21K 0.02% 404
2025
Q2
$1.31M Buy
4,158
+884
+27% +$255K 0.02% 409
2025
Q1
$860K Buy
+3,274
New +$886K 0.01% 434

Other funds holding PODD

ASR Vermogensbeheer's PODD Position: Q2 2026 in Review

ASR Vermogensbeheer sold out of Insulet (PODD) in Q2 2026, closing a stake of 4,174 shares — an estimated $876K sold.

ASR Vermogensbeheer first reported a position in PODD in Q1 2025 and held it in 5 quarters. The position peaked at $1.31M in Q2 2025. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • ASR Vermogensbeheer reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • ASR Vermogensbeheer sold 4,174 Insulet shares in Q2 2026, an estimated $876K.
  • ASR Vermogensbeheer first reported a position in Insulet in Q1 2025 and held it in 5 quarters.
  • ASR Vermogensbeheer's Insulet position peaked at $1.31M in Q2 2025.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.